nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—malignant glioma	0.94	1	CbGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000314	0.00525	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—BDKRB2—malignant glioma	0.000311	0.0052	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000311	0.0052	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000305	0.0051	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LATS1—malignant glioma	0.000297	0.00496	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000296	0.00494	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000291	0.00487	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.00029	0.00484	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000286	0.00478	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—KNG1—malignant glioma	0.000283	0.00474	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000273	0.00457	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000271	0.00453	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR4—malignant glioma	0.000259	0.00433	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000258	0.00431	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000255	0.00425	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000244	0.00408	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000242	0.00404	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000241	0.00402	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	0.00024	0.00401	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR4—malignant glioma	0.000235	0.00393	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	0.00023	0.00384	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	0.000229	0.00383	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000221	0.00369	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	0.000217	0.00362	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000208	0.00348	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDK—malignant glioma	0.0002	0.00335	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	0.000196	0.00327	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCR3—malignant glioma	0.000192	0.00322	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000192	0.0032	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DTX1—malignant glioma	0.000191	0.00319	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000187	0.00313	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—F2—malignant glioma	0.000183	0.00306	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—RTEL1—malignant glioma	0.00018	0.003	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000179	0.00298	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000177	0.00296	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—BDKRB2—malignant glioma	0.000176	0.00294	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCR3—malignant glioma	0.000175	0.00292	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	0.000175	0.00292	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	0.000172	0.00287	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000172	0.00287	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000169	0.00283	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000167	0.0028	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	0.000167	0.00279	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	0.000164	0.00274	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000162	0.00271	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—KNG1—malignant glioma	0.00016	0.00268	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—BDKRB2—malignant glioma	0.00016	0.00267	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00016	0.00267	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000158	0.00265	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000158	0.00264	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SUFU—malignant glioma	0.000152	0.00254	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HEY2—malignant glioma	0.00015	0.00251	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GFAP—malignant glioma	0.000147	0.00245	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	0.000146	0.00245	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KNG1—malignant glioma	0.000145	0.00243	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000145	0.00243	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000144	0.0024	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SPHK1—malignant glioma	0.000142	0.00237	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR4—malignant glioma	0.000139	0.00232	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HEY1—malignant glioma	0.000139	0.00232	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HIST1H3B—malignant glioma	0.000135	0.00225	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	0.00013	0.00217	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—malignant glioma	0.000129	0.00216	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MMP3—malignant glioma	0.000129	0.00215	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000129	0.00215	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000128	0.00215	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000124	0.00208	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JAG2—malignant glioma	0.000123	0.00206	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	0.000121	0.00202	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	0.000118	0.00198	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	0.000116	0.00193	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	0.000116	0.00193	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—malignant glioma	0.000115	0.00193	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000115	0.00192	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000112	0.00186	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00011	0.00184	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	0.000109	0.00183	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	0.000109	0.00182	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	0.000106	0.00178	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—H3F3A—malignant glioma	0.000104	0.00174	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—F2—malignant glioma	0.000103	0.00173	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCR3—malignant glioma	0.000103	0.00173	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—COX8A—malignant glioma	0.000103	0.00172	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—YWHAE—malignant glioma	0.0001	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NTRK2—malignant glioma	0.0001	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FLT1—malignant glioma	0.0001	0.00167	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DUSP6—malignant glioma	9.95e-05	0.00166	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CG—malignant glioma	9.9e-05	0.00166	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BCAN—malignant glioma	9.85e-05	0.00165	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JAG1—malignant glioma	9.83e-05	0.00164	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH3—malignant glioma	9.79e-05	0.00164	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FBXW7—malignant glioma	9.63e-05	0.00161	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BDKRB2—malignant glioma	9.44e-05	0.00158	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—F2—malignant glioma	9.4e-05	0.00157	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	9.39e-05	0.00157	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.22e-05	0.00154	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT2—malignant glioma	9.06e-05	0.00151	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MYC—malignant glioma	9.02e-05	0.00151	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CG—malignant glioma	8.99e-05	0.0015	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	8.91e-05	0.00149	CbGpPWpGaD
Tafluprost—PTGS2—Disease—DTX1—malignant glioma	8.91e-05	0.00149	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PTPN11—malignant glioma	8.84e-05	0.00148	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	8.82e-05	0.00147	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	8.78e-05	0.00147	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH2—malignant glioma	8.78e-05	0.00147	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ASMT—malignant glioma	8.77e-05	0.00147	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	8.75e-05	0.00146	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CD—malignant glioma	8.71e-05	0.00146	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	8.66e-05	0.00145	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KNG1—malignant glioma	8.59e-05	0.00144	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.58e-05	0.00143	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—malignant glioma	8.4e-05	0.0014	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BCAN—malignant glioma	8.25e-05	0.00138	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT2—malignant glioma	8.23e-05	0.00138	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NTRK1—malignant glioma	8.19e-05	0.00137	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—malignant glioma	7.91e-05	0.00132	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	7.86e-05	0.00131	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP3—malignant glioma	7.61e-05	0.00127	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—malignant glioma	7.59e-05	0.00127	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN2B—malignant glioma	7.54e-05	0.00126	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—malignant glioma	7.41e-05	0.00124	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	7.38e-05	0.00123	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTK2—malignant glioma	7.33e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—malignant glioma	7.29e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HES1—malignant glioma	7.2e-05	0.0012	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NCOR1—malignant glioma	7.16e-05	0.0012	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RAF1—malignant glioma	7.06e-05	0.00118	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HEY2—malignant glioma	6.99e-05	0.00117	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—malignant glioma	6.97e-05	0.00116	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—malignant glioma	6.89e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFRA—malignant glioma	6.85e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IDH1—malignant glioma	6.83e-05	0.00114	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	6.67e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SPP1—malignant glioma	6.65e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—IDH2—malignant glioma	6.65e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—malignant glioma	6.62e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HEY1—malignant glioma	6.47e-05	0.00108	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—malignant glioma	6.33e-05	0.00106	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TERT—malignant glioma	6.31e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HIST1H3B—malignant glioma	6.29e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.27e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2B6—malignant glioma	6.25e-05	0.00104	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFB—malignant glioma	6.16e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.14e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGFR1—malignant glioma	6.12e-05	0.00102	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HIF1A—malignant glioma	6.03e-05	0.00101	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6e-05	0.001	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CAV1—malignant glioma	5.83e-05	0.000975	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KDR—malignant glioma	5.77e-05	0.000964	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JAG2—malignant glioma	5.74e-05	0.000959	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—IDH1—malignant glioma	5.72e-05	0.000956	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.72e-05	0.000955	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.67e-05	0.000947	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—F2—malignant glioma	5.55e-05	0.000928	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FN1—malignant glioma	5.55e-05	0.000928	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SPHK1—malignant glioma	5.53e-05	0.000925	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BAD—malignant glioma	5.49e-05	0.000917	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH1—malignant glioma	5.43e-05	0.000908	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2C18—malignant glioma	5.42e-05	0.000906	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD80—malignant glioma	5.32e-05	0.00089	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APC—malignant glioma	5.31e-05	0.000888	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—malignant glioma	5.31e-05	0.000888	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGF—malignant glioma	5.25e-05	0.000878	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTPN11—malignant glioma	5.22e-05	0.000872	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.21e-05	0.00087	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.11e-05	0.000854	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.04e-05	0.000842	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BRAF—malignant glioma	4.99e-05	0.000835	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT2—malignant glioma	4.86e-05	0.000812	CbGpPWpGaD
Tafluprost—PTGS2—Disease—H3F3A—malignant glioma	4.86e-05	0.000812	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EGFR—malignant glioma	4.84e-05	0.000809	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—malignant glioma	4.67e-05	0.000781	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.66e-05	0.000778	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—malignant glioma	4.63e-05	0.000773	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JAG1—malignant glioma	4.58e-05	0.000765	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—malignant glioma	4.57e-05	0.000764	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.49e-05	0.000751	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FBXW7—malignant glioma	4.49e-05	0.00075	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF2—malignant glioma	4.47e-05	0.000747	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTT1—malignant glioma	4.38e-05	0.000733	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.25e-05	0.000711	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—malignant glioma	4.2e-05	0.000702	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDM2—malignant glioma	4.18e-05	0.000699	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RAF1—malignant glioma	4.17e-05	0.000697	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB2—malignant glioma	4.13e-05	0.000689	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTGS1—malignant glioma	4.11e-05	0.000687	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.09e-05	0.000684	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—malignant glioma	4.07e-05	0.00068	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—malignant glioma	3.91e-05	0.000654	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BCHE—malignant glioma	3.82e-05	0.000638	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—malignant glioma	3.78e-05	0.000632	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC5A5—malignant glioma	3.77e-05	0.00063	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—malignant glioma	3.74e-05	0.000626	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—malignant glioma	3.74e-05	0.000625	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.57e-05	0.000596	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—malignant glioma	3.54e-05	0.000591	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTEN—malignant glioma	3.52e-05	0.000588	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN2B—malignant glioma	3.52e-05	0.000587	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—malignant glioma	3.43e-05	0.000574	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HES1—malignant glioma	3.35e-05	0.00056	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCOR1—malignant glioma	3.33e-05	0.000557	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFRA—malignant glioma	3.19e-05	0.000534	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—malignant glioma	3.18e-05	0.000531	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—malignant glioma	3.15e-05	0.000526	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.08e-05	0.000515	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTP1—malignant glioma	3.04e-05	0.000508	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAT—malignant glioma	2.96e-05	0.000494	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TERT—malignant glioma	2.94e-05	0.000491	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HLA-A—malignant glioma	2.94e-05	0.000491	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—malignant glioma	2.92e-05	0.000489	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFB—malignant glioma	2.87e-05	0.000479	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGFR—malignant glioma	2.86e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGFR1—malignant glioma	2.85e-05	0.000477	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HIF1A—malignant glioma	2.81e-05	0.00047	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOR1—malignant glioma	2.79e-05	0.000467	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CAV1—malignant glioma	2.72e-05	0.000454	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—malignant glioma	2.7e-05	0.000451	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BAD—malignant glioma	2.56e-05	0.000427	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOTCH1—malignant glioma	2.53e-05	0.000423	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—malignant glioma	2.48e-05	0.000415	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD80—malignant glioma	2.48e-05	0.000415	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APC—malignant glioma	2.48e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGF—malignant glioma	2.45e-05	0.000409	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTPN11—malignant glioma	2.43e-05	0.000406	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—malignant glioma	2.4e-05	0.000401	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BRAF—malignant glioma	2.33e-05	0.000389	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAV1—malignant glioma	2.28e-05	0.00038	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT2—malignant glioma	2.27e-05	0.000379	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—malignant glioma	2.18e-05	0.000364	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.17e-05	0.000363	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF2—malignant glioma	2.08e-05	0.000348	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—malignant glioma	2.07e-05	0.000347	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—malignant glioma	2.03e-05	0.000339	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—malignant glioma	2e-05	0.000334	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MDM2—malignant glioma	1.95e-05	0.000326	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RAF1—malignant glioma	1.94e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB2—malignant glioma	1.92e-05	0.000321	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—malignant glioma	1.9e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—malignant glioma	1.82e-05	0.000305	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTEN—malignant glioma	1.64e-05	0.000274	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—malignant glioma	1.59e-05	0.000266	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—malignant glioma	1.47e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTEN—malignant glioma	1.37e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—malignant glioma	1.36e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGFR—malignant glioma	1.33e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—malignant glioma	1.26e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—malignant glioma	1.16e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—malignant glioma	9.69e-06	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—malignant glioma	9.45e-06	0.000158	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—malignant glioma	7.91e-06	0.000132	CbGpPWpGaD
